1. Home
  2. DCTH vs TG Comparison

DCTH vs TG Comparison

Compare DCTH & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$10.36

Market Cap

350.7M

Sector

Health Care

ML Signal

HOLD

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$7.46

Market Cap

301.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCTH
TG
Founded
1988
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
350.7M
301.0M
IPO Year
N/A
1989

Fundamental Metrics

Financial Performance
Metric
DCTH
TG
Price
$10.36
$7.46
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$22.60
N/A
AVG Volume (30 Days)
505.0K
167.3K
Earning Date
11-04-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
$79,603,000.00
$691,173,000.00
Revenue This Year
$131.69
N/A
Revenue Next Year
$39.22
N/A
P/E Ratio
$305.16
$112.43
Revenue Growth
251.54
43.30
52 Week Low
$8.12
$6.25
52 Week High
$18.23
$9.43

Technical Indicators

Market Signals
Indicator
DCTH
TG
Relative Strength Index (RSI) 56.86 49.07
Support Level $9.69 $7.10
Resistance Level $10.86 $7.56
Average True Range (ATR) 0.33 0.20
MACD 0.02 0.01
Stochastic Oscillator 54.70 72.73

Price Performance

Historical Comparison
DCTH
TG

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

Share on Social Networks: